If this email does not display properly, please View as Webpage
PCSS to Host Three Round Table
Discussions on Naltrexone
Naltrexone is an opioid antagonist medication that works by blocking the effects of opioids. Naltrexone prevents relapse and can also be used by patients who have been in treatment and have tapered off buprenorphine as an added protection against relapse.

These one-hour discussions are designed to support interactions among experts and health professionals in the field through an informal "round table" conversation. All attendees are asked to submit questions or a case study prior to the discussion.

Take advantage of this unique opportunity to engage with colleagues and experts to discuss and answer clinical cases/questions! 

NOTE: PCSS will post FAQs following the discussions.



Topic: XR-NTX in Clinical Practice: Practical Steps to Maximize Effectiveness 
Date: Thursday, August 29, 2019
Time: 12 - 1 pm ET
Presenter: Marc Fishman, MD, DFASAM


Topic: Navigating Clinical Challenges in Using XR-NTX: Starting with the First
Injection and Beyond
Date: Thursday, September 5, 2019
Time: 12 - 1 pm ET
Presenter: Robin Williams, MD


Topic: Use of Naltrexone for Opioid Use Disorder in the Fentanyl Era
Date: Thursday, September 12, 2019
Time: 12 - 1 pm ET
Presenter: John Mariani, MD

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.